Natural OTCs prepare for lift off
This article was originally published in OTC Bulletin & The Rose Sheet
Increasing demand for more natural products is opening up an enticing opportunity for consumer healthcare players.Tom Gallen explores the tools firms can use to make their brands stand out in this growing market.
You may also be interested in...
GSK launches Robitussin Naturals drug-free cough and cold remedies in the first naturals offering under the top-selling OTC drug brand. The line includes liquids and gummies for adults and children formulated with honey, ivy leaf and eucalyptus.
A WHO recommendation to explicitly exempt low-THC CBD from international narcotics controls has been emphatically rejected by UN member states. The CBD industry had hoped for a positive outcome to remove regulatory pressure on product manufacturers in Europe and around the world.
After its historic first emergency approval, analysts at Bernstein has upgraded predictions for Pfizer/BioNTech's COVID-19 vaccine in 2021 and beyond.